Form Bio Co. Ltd. Cash Flow Conversion Efficiency

Latest as of June 2026: -0.066x

Form Bio Co. Ltd. cash flow conversion efficiency. Based on the latest financial reports, Form Bio Co. Ltd. (377220) has a cash flow conversion efficiency ratio of -0.066x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.40 Billion ≈ $-950.36K USD) by net assets (₩21.22 Billion ≈ $14.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Form Bio Co. Ltd. (2019–2025)

Cash flow conversion efficiency of Form Bio Co. Ltd. from 2019 to 2025. This chart illustrates how Form Bio Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View 377220 share price today for real-time trading data and today's change.

Form Bio Co. Ltd. Cash Flow Conversion Ratio Explained

Form Bio Co. Ltd. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Form Bio Co. Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Form Bio Co. Ltd. ranked by their cash flow conversion efficiency. Also see 377220 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Baosheng Media Group Holdings Ltd NASDAQ:BAOS	-0.522x
Media Lab SpA PA:MLLAB	N/A
E Investment & Development KO:093230	-0.020x
RareX Limited F:CK1	-0.102x
Chukai Public Company Limited BK:CRANE	0.026x
Utilico Emerging Markets Ltd LSE:UEM	0.009x
ARIP Public Company Limited BK:ARIP	0.160x
Pacific Ridge Exploration Ltd V:PEX	-0.082x

Annual Cash Flow Conversion Efficiency for Form Bio Co. Ltd. (2019–2025)

The table below shows the annual cash flow conversion efficiency of Form Bio Co. Ltd. from 2019 to 2025. Review Form Bio Co. Ltd. free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩26.14 Billion ≈ $17.71 Million	₩-10.07 Billion ≈ $-6.83 Million	-0.385x	-28.71%
2024-12-31	₩49.10 Billion ≈ $33.28 Million	₩-14.70 Billion ≈ $-9.96 Million	-0.299x	-7.96%
2023-12-31	₩75.17 Billion ≈ $50.94 Million	₩-20.85 Billion ≈ $-14.13 Million	-0.277x	-1105.44%
2022-12-31	₩87.96 Billion ≈ $59.61 Million	₩-2.02 Billion ≈ $-1.37 Million	-0.023x	-65.33%
2021-12-31	₩84.43 Billion ≈ $57.22 Million	₩-1.17 Billion ≈ $-796.13K	-0.014x	-102.11%
2020-12-31	₩23.64 Billion ≈ $16.02 Million	₩15.61 Billion ≈ $10.58 Million	0.660x	+218.72%
2019-12-31	₩-10.21 Billion ≈ $-6.92 Million	₩5.68 Billion ≈ $3.85 Million	-0.556x	--

About Form Bio Co. Ltd.

KQ:377220 Korea Packaged Foods

Market Cap

$5.68 Million

₩8.38 Billion KRW

Market Cap Rank

#28242 Global

#2062 in Korea

Share Price

₩1480.00

Change (1 day)

-3.90%

52-Week Range

₩513.00 - ₩3685.00

All Time High

₩9925.00